Reckitt Benckiser Group plc (LON:RKT) Stock Has Average Price Target of GBX 5,925.33 According to Analysts

Reckitt Benckiser Group plc (LON:RKT - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six research firms that are presently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is GBX 5,925.33.

A number of research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a GBX 5,400 price objective on shares of Reckitt Benckiser Group in a report on Thursday, July 30th. Jefferies Financial Group dropped their price target on Reckitt Benckiser Group from GBX 6,100 to GBX 5,900 and set a "buy" rating for the company in a research report on Thursday, October 1st. Berenberg Bank boosted their price objective on shares of Reckitt Benckiser Group from GBX 5,179 to GBX 5,352 and gave the company a "hold" rating in a research report on Wednesday, August 5th. JPMorgan Chase & Co. raised their price target on Reckitt Benckiser Group from GBX 5,800 to GBX 6,500 and gave the stock an "overweight" rating in a research note on Tuesday, September 1st. Finally, Royal Bank Of Canada reissued a "sector perform" rating and set a GBX 6,200 price objective on shares of Reckitt Benckiser Group in a research note on Wednesday, July 29th.

Insider Buying and Selling at Reckitt Benckiser Group

In other Reckitt Benckiser Group news, insider Deborah Waterhouse purchased 152 shares of the firm's stock in a transaction that occurred on Wednesday, August 26th. The stock was purchased at an average cost of GBX 5,189 per share, with a total value of £7,887.28. Also, insider Gavin Patterson bought 191 shares of the firm's stock in a transaction dated Wednesday, August 26th. The stock was bought at an average cost of GBX 5,183 per share, with a total value of £9,899.53. Insiders own 0.44% of the company's stock.

Reckitt Benckiser Group Stock Down 0.1%

LON:RKT traded down GBX 6 during mid-day trading on Friday, hitting GBX 5,480. 1,327,754 shares of the company's stock traded hands, compared to its average volume of 21,354,479. The company has a fifty day moving average of GBX 5,097.17 and a 200 day moving average of GBX 4,956.68. The company has a market capitalization of £34.74 billion, a P/E ratio of 12.41, a P/E/G ratio of 1.10 and a beta of 0.26. The company has a debt-to-equity ratio of 179.24, a quick ratio of 0.46 and a current ratio of 0.59. Reckitt Benckiser Group has a twelve month low of GBX 3,866 and a twelve month high of GBX 6,522.92.

Reckitt Benckiser Group (LON:RKT - Get Free Report) last released its earnings results on Wednesday, July 29th. The company reported GBX 101.40 earnings per share (EPS) for the quarter. Reckitt Benckiser Group had a net margin of 21.09% and a return on equity of 42.87%. On average, analysts forecast that Reckitt Benckiser Group will post 331.21 EPS for the current year.

About Reckitt Benckiser Group

At Reckitt, we protect, heal and nurture. We are the company behind some of the world's best known and most trusted Health and Hygiene consumer brands. Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years. We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide. At Reckitt, we're all making a real difference to people all over the world, every day.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.